PTCB Immunization key terms

A severe, sudden allergic reaction that can cause trouble breathing, swelling of the face or throat, a dangerous drop in blood pressure, and loss of consciousness. It requires immediate epinephrine injection and emergency medical care.

A hormone drug given by intramuscular injection into the outer thigh to reverse the life-threatening effects of anaphylaxis. Pharmacy staff must know its location, dose, and expiration date before giving any vaccine.

A stocked, easily accessible supply kept at every immunization site that contains epinephrine, syringes, alcohol pads, gloves, a blood pressure cuff, and a means to call for help. Contents are checked regularly for expiration.

A required waiting time, commonly 15 minutes, after a vaccine is given so staff can watch for immediate reactions such as fainting or anaphylaxis. Patients with a history of immediate reactions may be observed longer.

A brief loss of consciousness caused by a temporary drop in blood flow to the brain, often triggered by needle anxiety. Patients should be seated or lying down during vaccination and watched afterward to prevent injury from falls.

The process of documenting and submitting a suspected side effect after vaccination to the national reporting system. Reports are required for serious events, medication errors, and events listed in product labeling.

An unwanted or harmful response that occurs after a vaccine is given, ranging from mild soreness and low fever to rare serious problems. Staff assess, document, and report reactions according to policy.

A condition or situation in which a vaccine should not be given because the risk of harm clearly outweighs any benefit. Examples include a severe allergic reaction to a prior dose or a vaccine component.

A condition that might increase the chance of an adverse reaction or reduce vaccine effectiveness, so the vaccine is delayed or given with extra caution. It differs from a contraindication, which means do not give the vaccine.

A set of questions asked before vaccination to identify allergies, prior reactions, pregnancy, immune status, bleeding disorders, and current illness. Answers guide the decision to give, delay, or refer the vaccine.

The process of explaining the vaccine's benefits and risks and obtaining the patient's or caregiver's permission before administration. It is usually documented with a signature and the date the information was provided.

A federally required, plain-language handout that explains the benefits and risks of a vaccine. It must be given to the patient or caregiver before each dose, and the edition date is recorded.

A confidential, population-based electronic registry that records vaccines a patient has received. Pharmacists use it to check history, avoid duplicate doses, and report administered doses as required by state rules.

The required written record of each vaccine given, including date, product name, lot number, expiration date, dose, site and route, administrator name and title, and the date the information statement was provided.

A manufacturer's identifier printed on each vaccine package that links a dose to a specific production batch. It is recorded at administration and used to trace problems or recalls.

The date after which a vaccine must not be used, as printed by the manufacturer. It may change once a vial is punctured, so beyond-use dates must be tracked separately.

The last date a vaccine may be used after it has been opened, punctured, or reconstituted, based on manufacturer instructions. It is written on the vial and can be shorter than the printed expiration date.

The unbroken sequence of proper temperature control from manufacture through storage to administration. Any break can reduce vaccine potency, and affected doses must not be used until assessed.

A written or electronic record of refrigerator and freezer temperatures taken at least daily. It shows trends and helps identify excursions so vaccine quality can be evaluated.

A device placed with stored vaccine that continuously records temperature at set intervals. Its readings are reviewed to confirm storage conditions and to investigate any out-of-range event.

Any time stored vaccine goes outside the recommended temperature range. The affected vaccine must be labeled do not use, kept properly stored, and evaluated with the manufacturer before any decision to discard.

A container holding more than one dose of vaccine that is entered repeatedly with a needle. Puncturing starts a beyond-use clock, and the vial must be discarded once that date passes.

A container holding one dose of vaccine with no preservative, intended for one patient only. It cannot be saved or reused, and any leftover product is discarded.

Mixing a powdered vaccine with its specific liquid diluent just before use. Only the diluent supplied by the manufacturer may be used, and the resulting product has a limited beyond-use date.

Practices that keep vaccines and injection supplies free of contamination, such as hand hygiene, cleaning the vial stopper, using a new needle and syringe per patient, and never reusing or sharing equipment.

The specific body location chosen for a vaccine, such as the deltoid muscle in older children and adults or the outer thigh in infants. Correct site selection reduces injury and improves immune response.

Delivering vaccine deep into a muscle, usually the deltoid in adults, using a needle long enough to reach muscle tissue. This route is used for most inactivated vaccines.

Delivering vaccine into the fatty tissue just under the skin, often at the outer upper arm or thigh, at a shallow angle. Only vaccines labeled for this route should be given this way.

The needle size chosen based on the patient's age, weight, and body size so vaccine reaches the correct tissue depth. Too short a needle can leave vaccine in fat and weaken the response.

Pulling back on the syringe plunger before injecting. Current guidance does not recommend it for routine vaccine injections because it is unnecessary and may cause pain or needle movement.

Placing used needles and syringes immediately into a puncture-resistant, closable container kept near the work area. Containers are never overfilled and are replaced when about three-quarters full.

The shortest acceptable time between doses of a vaccine series. Doses given too early may not count and often must be repeated, so schedules are checked before administration.

The recommended ages and spacing for each vaccine, published by national advisory committees and updated yearly. Pharmacists follow it to decide which vaccines a patient needs now.

Giving missed doses to a patient who is behind on the recommended schedule. It relies on documented history and minimum intervals to bring the patient up to date safely.

The legal rule that determines whether a pharmacist may give a vaccine under a standing order, protocol, or patient-specific prescription. Authority varies by state and by the patient's age.

A written authorization signed by a prescriber that allows pharmacists to give specified vaccines to defined patients without a separate prescription for each person. It states the vaccine, population, and conditions.

The set of activities a health professional is legally permitted to perform under state law and licensure. For immunizing pharmacists it defines which vaccines, ages, and authorities are allowed.

Any health problem that follows vaccination, whether or not it was caused by the vaccine. Recognizing and reporting these events supports national safety monitoring.